Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fook T Lee

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2003
Immuno-PET for tumor targetingFook T Lee, Andrew M Scott
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer modelMarcus P Kelly, Fook T Lee, Fiona E Smyth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Radioimmunotherapy with alpha-particle emitting 213Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 is enhanced by combination with paclitaxel chemotherapyMarcus P Kelly, Fook T Lee, Kiki Tahtis, et al.
Urologic Oncology|June 16, 2009
Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CTNathan Lawrentschuk, Fook T Lee, Gareth Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478Fook T Lee, Angela J Mountain, Marcus P Kelly, et al.
Molecular Imaging|July 27, 2016
L-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing AntibodiesFook T Lee, Ingrid J G Burvenich, Nancy Guo, et al.
Mabs|April 1, 2016
Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptorIngrid J G Burvenich, William Farrugia, Fook T Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Molecular imaging of death receptor 5 occupancy and saturation kinetics in vivo by humanized monoclonal antibody CS-1008Ingrid J G Burvenich, Fook T Lee, Glenn A Cartwright, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2010
Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806Fook T Lee, Graeme J O'Keefe, Hui K Gan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2003
Immuno-PET for tumor targetingFook T Lee, Andrew M Scott
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 6, 2006
Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer modelMarcus P Kelly, Fook T Lee, Fiona E Smyth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Radioimmunotherapy with alpha-particle emitting 213Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 is enhanced by combination with paclitaxel chemotherapyMarcus P Kelly, Fook T Lee, Kiki Tahtis, et al.
Urologic Oncology|June 16, 2009
Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CTNathan Lawrentschuk, Fook T Lee, Gareth Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478Fook T Lee, Angela J Mountain, Marcus P Kelly, et al.
Molecular Imaging|July 27, 2016
L-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing AntibodiesFook T Lee, Ingrid J G Burvenich, Nancy Guo, et al.
Mabs|April 1, 2016
Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptorIngrid J G Burvenich, William Farrugia, Fook T Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Molecular imaging of death receptor 5 occupancy and saturation kinetics in vivo by humanized monoclonal antibody CS-1008Ingrid J G Burvenich, Fook T Lee, Glenn A Cartwright, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2010
Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806Fook T Lee, Graeme J O'Keefe, Hui K Gan, et al.
Pageof 1